antiretroviral therapy Press Release

Title Picture
10/04/2018 - 10:22
Mercks HIV Therapy DELSTRIGO (doravirine / lamivudine / tenofovir disoproxil fumarate) Meets Primary Efficacy Endpoint in Phase 3 DRIVE-SHIFT Study Evaluating Switch to DELSTRIGO from Other Antiretroviral Treatment Regimens
Merck's picture
Merck
10/04/2018 - 09:15
Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-AHEAD Study Evaluating DELSTRIGO (doravirine / lamivudine / tenofovir disoproxil fumarate) for the Treatment of HIV-1 in Treatment-Naive Patients
Merck's picture
Merck
10/03/2018 - 15:24
Antiretroviral Therapy with Efavirenz in HIV-Positive Pregnant Women Likely Increases Risk of Neurological Condition in Children
Infectious Diseases Society of America's picture
Infectious Dise...
10/03/2018 - 08:57
Leading Infectious Diseases Experts Honored at IDWeek 2018 for Outstanding Work in Patient Care, Research, Public Health and Education
Infectious Diseases Society of America's picture
Infectious Dise...
09/26/2018 - 07:29
Combination HIV antibody infusions safely maintain viral suppression in select individuals
NIH's picture
NIH
09/26/2018 - 07:06
In clinical trials, new antibody therapy controls HIV for months after treatment
RockefellerUniversity's picture
RockefellerUniv...
09/20/2018 - 10:39
NIH launches study to test combination antibody treatment for HIV infection
NIH's picture
NIH
09/20/2018 - 02:15
Merck Receives Positive CHMP Opinion for DELSTRIGO (doravirine/lamivudine/tenofovir disoproxil fumarate) and PIFELTRO (doravirine) in the European Union for the Treatment of HIV-1 Infection
Merck's picture
Merck
09/17/2018 - 20:37
WHO calls for urgent action to end TB
WHO's picture
WHO
09/17/2018 - 12:27
FRESH program combines basic science with social benefits for women at risk of HIV
Ragon Institute's picture
Ragon Institute
09/14/2018 - 07:08
ViiV Healthcare submits regulatory application to European Medicines Agency for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV
GlaxoSmithKline's picture
GlaxoSmithKline
08/30/2018 - 19:41
FDA Approves Mercks DELSTRIGO (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO (doravirine), an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients
Merck's picture
Merck
08/28/2018 - 11:46
HIV/AIDS research yields dividends across medical fields
NIH's picture
NIH
08/21/2018 - 09:05
NIH officials: closing treatment gaps critical to ending the U.S. HIV epidemic
NIH's picture
NIH
08/15/2018 - 16:30
ViiV Healthcare reports positive 48-week results for first pivotal, phase III study for novel, long-acting, injectable HIV-treatment regimen
GlaxoSmithKline's picture
GlaxoSmithKline
08/13/2018 - 17:09
Brief interventions during routine care reduce alcohol use among men with HIV
BrownUniversity's picture
BrownUniversity
08/06/2018 - 21:31
Balzer, International Team Lead Community-Based HIV Trial in East Africa
University of Massachusetts Amherst's picture
University of M...
07/25/2018 - 12:16
Fauci: HIV remission free of antiretroviral therapy is a feasible goal
NIH's picture
NIH
07/25/2018 - 12:04
Multi-disease health fairs, universal test and treat help East African communities achieve HIV benchmarks
NIH's picture
NIH
07/25/2018 - 09:44
New Data Show Dramatic Progress in Namibia Toward HIV Epidemic Control and Substantial Gaps in Cote d'Ivoire and Cameroon
CDC's picture
CDC
07/25/2018 - 02:53
Hologic's Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries
Hologic's picture
Hologic
07/24/2018 - 17:33
Abbott Introduces Breakthrough Point-of-Care Test, the m-PIMA HIV-1/2 Viral Load (VL), at AIDS 2018 Amsterdam
Abbott's picture
Abbott
07/24/2018 - 15:22
Janssen announces JULUCA (dolutegravir/rilpivirine) maintains viral suppression with two drugs in a once-daily, single-pill
Johnson and Johnson's picture
Johnson and Johnson
07/12/2018 - 15:19
Imaging technique illuminates immune status of monkeys with HIV-like virus
NIH's picture
NIH
06/29/2018 - 18:36
Leading World-Class Investigations Into Infectious Diseases
Northwestern University's picture
Northwestern Un...
06/27/2018 - 15:48
HIV Test and Treat pilot project in Yambio comes to a close
MSF's picture
MSF
06/13/2018 - 22:11
ViiV Healthcare reports landmark phase III studies for dolutegravir and lamivudine, demonstrating the ability to control HIV with a two-drug regimen in treatment naive patients
GlaxoSmithKline's picture
GlaxoSmithKline
05/21/2018 - 08:51
Janssen Announces European Commission Approval of JULUCA (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1
Johnson and Johnson's picture
Johnson and Johnson
05/21/2018 - 04:41
ViiV Healthcare receives EU marketing authorisation for Juluca (dolutegravir/rilpivirine), the first 2-drug regimen, once-daily, single-pill for the treatment of HIV
GlaxoSmithKline's picture
GlaxoSmithKline
05/07/2018 - 06:27
NIH clinical trial to track outcomes of kidney transplantation from HIV-positive donors to HIV-positive recipients
NIH's picture
NIH
04/18/2018 - 12:40
Top HIV Cure Research Team Refutes Major Recent Results on How to Identify HIV Persistence
Wistar Institute's picture
Wistar Institute
03/23/2018 - 04:10
ViiV Healthcare gains CHMP positive opinion for Juluca (dolutegravir/rilpivirine) in Europe
GlaxoSmithKline's picture
GlaxoSmithKline
03/19/2018 - 06:00
The Campbell Foundation Awards $100,000 Grant to The Wistar Institute
Wistar Institute's picture
Wistar Institute
03/06/2018 - 12:49
Center for Drug Use and HIV/HCV Research at NYU Meyers Receives $7.5 Million in NIH Funding, Marking Centers 20th Anniversary
NewYorkUniversity's picture
NewYorkUniversity
03/05/2018 - 10:57
One-month tuberculosis prophylaxis as effective as nine-month regimen for people living with HIV
NIH's picture
NIH
03/05/2018 - 05:41
Broadly neutralizing antibody treatment may target viral reservoir in monkeys
NIH's picture
NIH
03/01/2018 - 09:22
Merck to Present New Data from Studies of Investigational HIV Therapies Doravirine and MK-8591 at CROI 2018
Merck's picture
Merck
02/19/2018 - 13:01
Center for HIV Cure Research
Gladstone Institutes's picture
Gladstone Institutes
02/15/2018 - 10:54
UCLA scientists receive $7.7 million grant to study HIV recurrence
UCLA's picture
UCLA
02/08/2018 - 07:09
ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment
GlaxoSmithKline's picture
GlaxoSmithKline
01/25/2018 - 16:12
Gene therapy using CAR T cells could provide long-term protection against HIV
UCLA's picture
UCLA
01/24/2018 - 01:43
15 years later, PEPFAR continues to save lives
NIH's picture
NIH
01/24/2018 - 01:05
Study links gut-homing protein levels with HIV infection risk, disease progression
NIH's picture
NIH
01/24/2018 - 01:04
NIH begins large HIV treatment study in pregnant women
NIH's picture
NIH
01/22/2018 - 03:32
Gladstone Launches Three New Research Centers
Gladstone Institutes's picture
Gladstone Institutes
01/04/2018 - 12:05
Roche launches the cobas Plasma Separation Card to increase access to HIV testing for patients living in remote areas
Rocheusa's picture
Rocheusa
12/23/2017 - 03:34
UNAIDS welcomes appointment of Henrietta Holsman Fore as Executive Director of UNICEF
UNAIDS's picture
UNAIDS
12/15/2017 - 09:17
Teva Announces Exclusive Launch of Generic Viread in the United States
Teva Pharmaceutical's picture
Teva Pharmaceutical
12/12/2017 - 21:19
Social stigma obstacle to successful treatment of children with HIV in Ethiopia
LundUniv's picture
LundUniv
12/12/2017 - 13:34
Michel C. Nussenzweig wins 2017 Sanofi-Institut Pasteur Award
RockefellerUniversity's picture
RockefellerUniv...
12/11/2017 - 14:23
Marijuana may help HIV patients keep mental stamina longer
Michigan State University's picture
Michigan State ...
12/06/2017 - 15:58
Huge progress in treating AIDS
Harvard's picture
Harvard
12/05/2017 - 19:04
West and Central Africa left behind in global HIV response
UNAIDS's picture
UNAIDS
12/01/2017 - 15:46
Six Caribbean territories and states eliminate mother-to-child transmission of HIV and syphilis
UNAIDS's picture
UNAIDS
12/01/2017 - 13:06
NIH Statement on World AIDS Day 2017
NIH's picture
NIH
12/01/2017 - 11:24
Ukraine: People co-infected with HIV to receive hepatitis C treatment in Mykolaiv region
MSF's picture
MSF
12/01/2017 - 10:09
Rising levels of HIV drug resistance
UniversityCollegeLondon's picture
UniversityColle...
11/29/2017 - 20:00
Combination HIV prevention reduces new infections by 42 percent in Ugandan district
NIH's picture
NIH
11/21/2017 - 02:23
Juluca (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection
GlaxoSmithKline's picture
GlaxoSmithKline
11/20/2017 - 01:31
UNAIDS announces nearly 21 million people living with HIV now on treatment
UNAIDS's picture
UNAIDS